PRESS RELEASE published on 01/24/2025 at 07:00, 1 year 4 months ago BB Biotech: Preliminary full-year 2024 results and dividend proposal BB Biotech AG reports preliminary full-year 2024 results with a net profit of CHF 76 mn, proposing a dividend of CHF 1.80 per share at the AGM on March 19, 2025, focusing on shareholder returns and biotech sector growth Preliminary Results Dividend Proposal Biotech Sector Shareholder Returns BB Biotech
PRESS RELEASE published on 01/24/2025 at 07:00, 1 year 4 months ago EQS-Adhoc: BB Biotech AG closes the 2024 fiscal year with a profit BB Biotech AG closes the 2024 fiscal year with a profit of approximately CHF 76 million, reflecting share price development. Preliminary unaudited figures show a significant improvement from the previous year Investment Company Preliminary Figures BB Biotech AG Profit 2024 Fiscal Year
BRIEF published on 01/22/2025 at 14:36, 1 year 4 months ago Edison Highlights BB Biotech's Portfolio Boost Acquisition Net Asset Value Investment Biotech Sector BB Biotech
PRESS RELEASE published on 01/22/2025 at 14:31, 1 year 4 months ago Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION) highlighting recent positive developments and implications for the biotech sector. Johnson & Johnson's acquisition of Intra-Cellular Therapies at a premium has boosted BB Biotech's net asset value Acquisition Edison Biotech Sector BB Biotech Johnson & Johnson
BRIEF published on 10/25/2024 at 07:05, 1 year 7 months ago BB Biotech AG Releases Interim Report with Positive Net Profit Investment Net Profit Biotech Sector Interim Report BB Biotech
BRIEF published on 10/25/2024 at 07:05, 1 year 7 months ago BB Biotech: Strategic Portfolio Reallocation Amid Volatile Markets Financial Results Investment Strategy Biotech Sector BB Biotech Portfolio Reallocation
PRESS RELEASE published on 10/25/2024 at 07:00, 1 year 7 months ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first nine months of 2024, showing a net profit and strategic investment details Investment Company Net Profit BB Biotech AG Interim Report Stocks
PRESS RELEASE published on 10/25/2024 at 07:00, 1 year 7 months ago BB Biotech: Strategic reallocation of portfolio assets progressing BB Biotech AG reports strategic portfolio reallocation progress in Q3 2024 amid market volatility, focusing on promising biotech investments. Key companies achieve milestones Investment BB Biotech AG Biotech Sector Milestones Portfolio Reallocation
BRIEF published on 10/23/2024 at 10:17, 1 year 7 months ago BB Biotech Sees Positive Developments Amid Sector Challenges Investment Opportunity Biotech Sector BB Biotech Share Price Discount RNA Editing
PRESS RELEASE published on 10/23/2024 at 10:12, 1 year 7 months ago Edison issues report on BB Biotech (BION) Edison releases report on BB Biotech, highlighting positive developments in genetic medicine and revenue prospects, offering investment opportunity at a wide discount Investment Opportunity Edison Discount BB Biotech Genetic Medicine
Published on 06/19/2026 at 01:20, 14 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 27 minutes ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 1 hour 34 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/18/2026 at 23:55, 1 hour 39 minutes ago Relevant Gold Announces Results of Annual and Special General Meeting and Welcomes New Board Member
Published on 06/19/2026 at 01:15, 18 minutes ago UV Laser Technology Gains Momentum in Europe for Clean, Cold Marking and High-Precision Engraving
Published on 06/18/2026 at 22:35, 2 hours 58 minutes ago Bitmine Immersion Technologies Announces Cash Dividend of $0.1056 per Share of 9.50% Series A Perpetual Preferred Stock
Published on 06/18/2026 at 22:00, 3 hours 34 minutes ago Blue Cap AG: Closing of the Acquisition of Janoschka AG Successfully Completed
Published on 06/18/2026 at 18:00, 7 hours 34 minutes ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 7 hours 49 minutes ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 7 hours 55 minutes ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
Published on 06/18/2026 at 09:06, 16 hours 27 minutes ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
